GW PHARMACEUTICALS Aktie OTC Markets

Aktier

2021-01-12	GW Pharmaceuticals plc Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-10-2021 through Jan-15-2021
2020-11-03	GW Pharmaceuticals plc, Q3 2020 Earnings Call, Nov 03, 2020
2020-09-15	GW Pharmaceuticals plc Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-15-2020 04:15 PM
2020-09-10	GW Pharmaceuticals plc Presents at Citi 15th Annual Biopharma Virtual Conference 2020, Sep-10-2020 04:15 PM
2020-08-06	GW Pharmaceuticals plc, Q2 2020 Earnings Call, Aug 06, 2020
2020-06-30	GW Pharmaceuticals plc - Special Call
2020-06-10	GW Pharmaceuticals plc Presents at Goldman Sachs 41st Annual Global Healthcare Conference, Jun-10-2020 10:20 AM
2020-05-12	GW Pharmaceuticals plc Presents at BofA Securities 2020 Health Care Conference, May-12-2020 01:40 PM
2020-05-11	GW Pharmaceuticals plc, Q1 2020 Earnings Call, May 11, 2020
2020-02-25	GW Pharmaceuticals plc, Q4 2019 Earnings Call, Feb 25, 2020
2020-01-14	GW Pharmaceuticals plc Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 through Jan-16-2020
2019-11-05	GW Pharmaceuticals plc, Q3 2019 Earnings Call, Nov 05, 2019
2019-09-11	GW Pharmaceuticals plc Presents at Morgan Stanley 17th Annual Global Healthcare Conference, Sep-11-2019 09:55 AM

2023-04-06	Fitch Affirms Jazz's IDR at 'BB-'; Outlook Positive
2023-01-23	Former President of GW Pharmaceuticals USA Joins Lexaria Bioscience as Strategic Advisor
2022-03-28	Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing
2022-03-02	JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS
2021-08-12	Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav

1 dag

+16,92 %

Verkställande direktör	Titel	Ålder	Sedan
Alkesh Patel SEC	Företagssekreterare	-	2024-04-03

Styrelseledamot	Titel	Ålder	Sedan
David Spackman BRD	Direktör/Styrelseledamot	50	2023-01-13
Amanda Flanagan BRD	Direktör/Styrelseledamot	55	2025-02-10

Lägg till i en lista 0 vald För att använda denna funktion måste du vara en kund eller medlem Logga in Registrera dig	Förändring	Utveckling 5 d	Varia. 1 år	Föränd. 3 år	Kapi.($)
GW PHARMACEUTICALS	+16,92 %	+17,65 %	-	-	6,91 md
WUXI APPTEC CO., LTD.	−4,83 %	+3,51 %	+55,00 %	+62,02 %	66,7 md
ARGENX SE	+0,02 %	+1,07 %	+11,72 %	+74,73 %	56,88 md
LONZA GROUP AG	−1,34 %	+2,98 %	+25,08 %	+98,39 %	56,53 md
BEONE MEDICINES AG	+5,09 %	+9,89 %	+27,19 %	+103,27 %	46,49 md
IQVIA HOLDINGS INC.	+2,62 %	+1,68 %	+29,16 %	+36,08 %	44,8 md
REVOLUTION MEDICINES, INC.	+8,24 %	+0,51 %	+215,16 %	+807,84 %	41,59 md
CELLTRION, INC.	−1,86 %	+10,13 %	+28,14 %	+53,61 %	35,35 md
GENMAB A/S	−2,97 %	−9,84 %	+90,91 %	+61,94 %	33,29 md
INSMED INCORPORATED	+5,19 %	+1,62 %	−39,69 %	+381,71 %	25,1 md
Genomsnitt	+2,71 %	+2,65 %	+49,18 %	+186,62 %	45,19 md
Viktad genomsnitt av Capi.	+0,92 %	+3,07 %	+49,90 %	+165,96 %